Recurrence of idiopathic thromboembolism during anticoagulant therapy.
Patients with acute pulmonary embolism and venous thromboembolism are usually treated with anticoagulant therapy for at least 3 months as the optimum duration. A patient with recurrent idiopathic venous thromboembolism at the eighth month during anticoagulation (warfarin to target international normalized ratio of 2.0-3.0) is described. The case suggests that patients with idiopathic venous thromboembolism have a high risk of recurrence, even if a strict anticoagulant regimen is followed.
Tanimoto
K
K
Second Department of Internal Medicine, Kagawa Medical University, Japan.
Mizushige
K
K
Yukiiri
K
K
Ueda
T
T
Yoshihiro
W
W
Ohmori
K
K
Kohno
M
M
D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D011655:Pulmonary Embolism / Q000188:drug therapy*; D012008:Recurrence; D013923:Thromboembolism / Q000188:drug therapy / Q000209:etiology*; D014859:Warfarin / Q000627:therapeutic use*
D000925:Anticoagulants; D014859:Warfarin